Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
378
6 regions29 stories14 countries
Top story
UK CBD industry expects first authorised products by spring 2025
In a long-awaited and major step forward for the UK’s CBD sector, the regulator has announced a new roadmap that could see the first products given official approval.
GBHemp & CBDlink no longer available
- 01
DEA's cannabis rescheduling hearing set to begin in January
USRegulationlink no longer available
- 02
Czech GPs will be able to prescribe medical cannabis starting next year
CZMedicallink no longer available
Europe
8 stories- Ananda expands cannabis trials in the UK to meet regulatory needs
GBMedicallink no longer available
- CBD shows promise as treatment option for endometriosis sufferers
Health & Sciencelink no longer available
- Business of Cannabis Berlin examines insights into Germany's cannabis future
DEEvents & Industrylink no longer available
- Releaf's training standards raise bar for UK medical cannabis compliance
GBMedicallink no longer available
- France's strict cannabis laws remain despite Europe's highest consumption
FRRegulationlink no longer available
- Flora Growth Corp. renews sales orders for Czech Republic and Slovakia
CZSKBusiness & Investmentlink no longer available
- High Tide launches new membership program across UK, US, and EU
GBUSEUBusiness & Investmentlink no longer available
- HYTN secures UK import permits and prepares international shipments
GBBusiness & Investmentlink no longer available
United States
6 stories- Blimburn Seeds announces global partnership with Steve DeAngelo
Business & Investmentlink no longer available
- Project Champion helps underserved cannabis farmers comply with regulations
USRegulationlink no longer available
- NAACP urges New York governor to prioritise cannabis equity
USRegulationlink no longer available
- USDA modifies hemp insurance and crop rotation rules
USHemp & CBDlink no longer available
- Nebraska attorney general plans Supreme Court challenge to medical marijuana
USRegulationlink no longer available
- Nevis Brands expands cannabis beverage licensing to new markets
USBusiness & Investmentlink no longer available
Canada
4 stories- Quebec's SQDC introduces cannabis vaping products for local consumers
CAAdult-uselink no longer available
- Avicanna delivers proprietary cannabis products to pharmaceutical company
CABusiness & Investmentlink no longer available
- Entourage Health improves revenue by 8% and reduces losses
CABusiness & Investmentlink no longer available
- Health Canada cannabis program faces $20 million budget reductions
CARegulationlink no longer available
LATAM & Caribbean
4 stories- Brazil surpasses 672,000 patients receiving medical cannabis treatments
BRMedicallink no longer available
- Brazilian cannabis parliamentary front announces selected 2024 government funding projects
BRBusiness & Investmentlink no longer available
- Costa Rica cancels proposed referendum on legalising recreational cannabis
CRAdult-uselink no longer available
- New provincial program promotes therapeutic cannabis use with enhanced access
Medicallink no longer available
Africa & Middle East
2 stories- Israeli Economy Ministry unveils plans to expand cannabis market competitiveness
ILRegulationlink no longer available
- South Africa's cannabis reform celebrated as industry marks key milestones
ZARegulationlink no longer available
Oceania
2 stories- Gro Vida secures Australian market partnership with Lyphe for medical cannabis
AUBusiness & Investmentlink no longer available
- Rua Bioscience seeks $3 million funding to expand medicinal cannabis operations
NZBusiness & Investmentlink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report